Kaup Allison R, Dunn Laura B, Saks Elyn R, Jeste Dilip V, Palmer Barton W
San Diego State University/University of California, San Diego, CA, USA.
IRB. 2011 Jul-Aug;33(4):1-9.
Despite substantial research on overall decision-making capacity (DMC) levels in schizophrenia, factors causing individuals to make errors during decision-making regarding research participation or treatment are relatively unknown.
We examined the responses of 84 middle-aged and older patients with schizophrenia or schizoaffective disorder on a structured DMC measure—the MacArthur Competence Assessment Tool for Clinical Research—to determine the frequency and apparent cause of patients’ errors.
Most errors were due to difficulty recalling the disclosed information (seen in 65.5% of patients), particularly the study’s procedures, potential risks/discomforts, and purpose. Errors attributable to concrete thinking, thought disorder or other psychotic symptoms, or perceived coercion were rarer.
Informed consent procedures might be improved for this population by providing information in a way that facilitates learning and memory, such as iterative disclosure of the information, corrective feedback, and emphasis of key points (e.g., the study’s purpose, procedures, and potential risks).
尽管对精神分裂症患者的整体决策能力(DMC)水平进行了大量研究,但导致个体在研究参与或治疗决策过程中犯错的因素仍相对不明。
我们使用一种结构化的DMC测量工具——麦克阿瑟临床研究能力评估工具,对84名中老年精神分裂症或分裂情感性障碍患者的反应进行了检查,以确定患者错误的频率和明显原因。
大多数错误是由于难以回忆所披露的信息(65.5%的患者出现这种情况),尤其是研究程序、潜在风险/不适以及目的。归因于具体思维、思维紊乱或其他精神病性症状,或感知到的强迫的错误则较少见。
对于这一人群,知情同意程序或许可以通过以促进学习和记忆的方式提供信息来加以改进,比如反复披露信息、提供纠正性反馈以及强调关键点(如研究目的、程序和潜在风险)。